We recently showed that
zerumbone, a
sesquiterpene found in subtropical ginger, suppresses colonic
tumor marker formation in rats and induces apoptosis in
colon cancer cell lines. In our present study, the anti-
tumor initiating and promoting activities of
zerumbone in mouse skin were evaluated using a conventional 2-stage
carcinogenesis model. A single topical pretreatment to mouse skin (2 micromol) 24 hr before application of dimethylbenz[a]
anthracene (0.2 micromol) markedly suppressed
tumor incidence by 60% and the number of
tumors by 80% per mouse. Repeated pretreatment (16 nmol) twice weekly during the post-initiation phase reduced the number of 12-O-tetradecanoylphorbol-13-acetate (TPA, 1.6 nmol)-induced
tumors by 83% as well as their diameter by 57%. Multiple
reverse transcriptase (RT) PCR experiments revealed that
zerumbone (2 micromol) enhanced the
mRNA expression level of
manganese superoxide dismutase,
glutathione peroxidase-1,
glutathione S-transferase-P1 and
NAD(P)H
quinone oxidoreductase in the epidermis, but not that of
cytochrome p450 1A1 or 1B1. Further, it diminished TPA-induced
cyclooxygenase-2 protein expression and phosphorylation of
extracellular signal-regulated kinase 1/2, while pretreatment(s), in either the priming or activation stage or both, reduced double TPA application-induced
hydrogen peroxide formation and
edema induction by 29% to 86%, respectively. Histologic examination revealed that pretreatment(s) with
zerumbone suppressed leukocyte infiltration and reduced
proliferating cell nuclear antigen-labeling indices. Together, our results indicate that
zerumbone is a promising agent for the prevention of both
tumor initiating and promoting processes, through induction of anti-oxidative and phase II
drug metabolizing
enzymes as well as attenuation of proinflammatory signaling pathways.